A Randomized, Blinded, Single Center and Parallel Controlled Trial for Evaluating the Immunogenicity and Safety of Sequential Inoculation of Type I & III Live Attenuated OPV (Human Diploid Cells) and IPV Vaccine for Infants Aged 2 Months
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Poliovirus vaccine live oral (Primary)
- Indications Poliomyelitis
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Beijing Tiantan Biological Products Company
- 26 Aug 2016 New trial record